Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

ET antagonists for asthma

Sep. 2, 1997

Anti-IgE antibody inhibits allergen-induced EAR

Sep. 2, 1997

North American clinical trials with LiquiVent to be reinitiated

Sep. 1, 1997

P&U cephem derivatives for inhibiting HLE

Aug. 29, 1997

FDA approves Hi-Tech's generic promethazine/codeine syrup

Aug. 28, 1997

Hoechst Marion Roussel reports new antiallergy agents

Aug. 25, 1997

New antiallergy agents described by Dainippon Ink

Aug. 20, 1997

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Cortecs announces phase II results for Pseudostat in chronic bronchitis

Aug. 14, 1997

FDA approves IND for cystic fibrosis drug

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...